News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova/X
Dec 28, 2024, 14:09

The new NCCN guidelines for immunotherapy-related toxicities

Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a post on X:

“The new ⁦National Comprehensive Cancer Network (NCCN)⁩ guidelines address a wide range of immunotherapy-related toxicities, including those associated with ICI, CAR T-cell therapy, and lymphocyte engagers.”

NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.

Authors: John A. Thompson, et al.

The new NCCN guidelines for immunotherapy-related toxicities

 

cancer CAR T-cell therapy Elvina Almuradova European School of Oncology fight against cancer Global fight against cancer ICI immunotherapy lymphocyte engagers National Comprehensive Cancer Network NCCN NCCN guidelines OncoDaily Oncology
Special Coverage
Blog
Aug 5, 2025, 16:13
Al-Ola Abdallah: Daniel Carrizosa Discussed Bispecific T-cell Engagers in SCLC at National ICE-T Conference
Science
Aug 5, 2025, 16:07
Hagop Kantarjian: Discussing the Biology of Acute Lymphocytic Leukaemia
Blog
Aug 5, 2025, 16:04
Loizos G. Loizou: ELPIDA Foundation for Children with Cancer and Leukaemia
Blog
Aug 5, 2025, 15:57
Fabio Ynoe de Moraes: Radiotherapy Can "Heat Up" Cold Lung Tumors and Boost Immunotherapy Responses
Blog
Aug 5, 2025, 15:32
Sumanta Pal: Our Terrific Surgeons are Blazing New Trails for Challenging to Treat Diseases
Opinion
Aug 5, 2025, 15:01
Timothy Winschel: Excited to Share Our Recent Paper Published in Supportive Care in Cancer
Career
Aug 5, 2025, 14:16
Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology
Blog
Aug 5, 2025, 13:23
Can Exercise Change Cancer Care?
Immune Oncology
Aug 5, 2025, 13:09
FDA Fast Track for CLD-201: Stem Cell–Based Oncolytic Virus for Soft Tissue Sarcoma
Insight
Aug 5, 2025, 12:52
Chris Boshoff: Pfizer’s Updates from the Second Quarter
Blog
Aug 5, 2025, 12:52
Davit Zohrabyan: Thanks to The Max Foundation for Giving Patients a Chance to Cancer Treatment
Insight
Aug 5, 2025, 12:39
Lorlatinib as First Treatment for ALK+ Lung Cancer - ALK Positive Inc.